Bonus BioGroup Management
Management criteria checks 3/4
Bonus BioGroup's CEO is Shai Meretzki, appointed in Apr 2012, has a tenure of 12.58 years. directly owns 32.97% of the company’s shares, worth ₪44.28M. The average tenure of the management team and the board of directors is 7.3 years and 8.4 years respectively.
Key information
Shai Meretzki
Chief executive officer
₪2.0m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 12.6yrs |
| CEO ownership | 33.0% |
| Management average tenure | 7.3yrs |
| Board average tenure | 8.4yrs |
Recent management updates
Recent updates
We're Keeping An Eye On Bonus BioGroup's (TLV:BONS) Cash Burn Rate
Apr 01
Will Bonus BioGroup (TLV:BONS) Spend Its Cash Wisely?
Dec 11We're Keeping An Eye On Bonus BioGroup's (TLV:BONS) Cash Burn Rate
Jun 14Is Bonus BioGroup (TLV:BONS) In A Good Position To Deliver On Growth Plans?
Dec 13Companies Like Bonus BioGroup (TLV:BONS) Are In A Position To Invest In Growth
Jun 26Here's Why We're Not Too Worried About Bonus BioGroup's (TLV:BONS) Cash Burn Situation
Jan 28Here's Why We're Not Too Worried About Bonus BioGroup's (TLV:BONS) Cash Burn Situation
Sep 15Here's What Bonus BioGroup Ltd.'s (TLV:BONS) Shareholder Ownership Structure Looks Like
Mar 05What Kind Of Investors Own Most Of Bonus BioGroup Ltd. (TLV:BONS)?
Nov 19CEO
Shai Meretzki (55 yo)
12.6yrs
Tenure
₪2,039,000
Compensation
Dr. Shai Meretzki, PhD is the Founder of Pluristem Therapeutics, Inc. and Bonus BioGroup Ltd (Formerly BoneUs Therapeutics Ltd). Dr. Meretzki founded the Bonus BioGroup Ltd. He has been the Chief Executive...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 12.6yrs | ₪1.54m | 11.48% ₪ 15.4m | |
| Founder | 12.6yrs | ₪2.04m | 32.97% ₪ 44.3m | |
| Chief Financial Officer | 10.4yrs | ₪804.00k | 0.19% ₪ 253.4k | |
| Chief Operations Officer | 3.8yrs | ₪749.00k | no data | |
| Head of Regulatory Affairs & VP of Clinical Affairs | 4.3yrs | no data | no data |
7.3yrs
Average Tenure
52yo
Average Age
Experienced Management: BONS's management team is seasoned and experienced (7.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 12.6yrs | ₪1.54m | 11.48% ₪ 15.4m | |
| Founder | 12.6yrs | ₪2.04m | 32.97% ₪ 44.3m | |
| Member of Business Advisory Board | no data | no data | no data | |
| Non-Executive Director | 12.6yrs | no data | 0.61% ₪ 817.2k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Non-Executive Director | 4.2yrs | no data | no data | |
| Independent Non-Executive Director | 4.2yrs | no data | no data | |
| Non-Executive Director | 4.2yrs | no data | no data | |
| Member of Business Advisory Board | no data | no data | no data |
8.4yrs
Average Tenure
65yo
Average Age
Experienced Board: BONS's board of directors are considered experienced (8.4 years average tenure).